We are live on ! Find out more
MDXG icon

MiMedx Group

202 hedge funds and large institutions have $657M invested in MiMedx Group in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 60

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

0.58% more ownership

Funds ownership: 63.68%64.27% (+0.58%)

0% more funds holding

Funds holding: 202202 (0)

9% less capital invested

Capital invested by funds: $721M → $657M (-$63.1M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

28% less call options, than puts

Call options by funds: $1.06M | Put options by funds: $1.47M

Holders
202
Holders Change
Holders Change %
0%
% of All Funds
2.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
29
Increased
70
Reduced
60
Closed
26
Calls
$1.06M
Puts
$1.47M
Net Calls
-$415K
Net Calls Change
-$1.45M
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$195M
BlackRock
2
BlackRock
New York
$64.5M +$1.02M +144,915 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$48M +$7.05M +1,002,782 +17%
TI
4
Trigran Investments
Illinois
$31M +$8.59M +1,221,797 +38%
PCMI
5
Paradigm Capital Management Inc
New York
$28.9M +$1.82M +258,700 +7%
State Street
6
State Street
Massachusetts
$27.5M -$6.85M -974,245 -20%
CC
7
Cannell Capital
Wyoming
$23M +$6.25M +888,452 +37%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$19.1M +$908K +129,138 +5%
Renaissance Technologies
9
Renaissance Technologies
New York
$10.9M -$1.31M -186,000 -11%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$10.3M +$1.59M +226,146 +18%
Charles Schwab
11
Charles Schwab
California
$9.3M +$1.2M +171,258 +15%
Morgan Stanley
12
Morgan Stanley
New York
$9.2M -$4.23M -601,658 -31%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$8.96M +$2.91M +413,443 +47%
PAIM
14
Punch & Associates Investment Management
Minnesota
$7.96M +$3.69M +524,914 +84%
Northern Trust
15
Northern Trust
Illinois
$7.09M -$207K -29,512 -3%
RA
16
Royce & Associates
New York
$6.41M +$195K +27,698 +3%
RB
17
Richmond Brothers
Michigan
$6.36M -$1.26M -179,673 -16%
Federated Hermes
18
Federated Hermes
Pennsylvania
$6.29M -$25.7K -3,650 -0.4%
Arrowstreet Capital
19
Arrowstreet Capital
Massachusetts
$6.26M -$190K -27,005 -3%
Millennium Management
20
Millennium Management
New York
$6.16M +$4.83M +687,267 +340%
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
$6M +$921K +131,031 +18%
Goldman Sachs
22
Goldman Sachs
New York
$4.85M +$525K +74,623 +12%
Two Sigma Investments
23
Two Sigma Investments
New York
$4.44M -$799K -113,699 -15%
Franklin Resources
24
Franklin Resources
California
$4.29M +$268K +38,161 +7%
Prudential Financial
25
Prudential Financial
New Jersey
$4.08M -$3.14M -447,090 -43%

MDXG Hedge Fund Activity: Q2 2024 in Review

202 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q2 2024, worth a combined $657M — down 8.8% from $721M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new MDXG positions and 26 closed out — a net gain of 3 holders — while 70 added to existing stakes and 60 trimmed.

The largest buyer was Trigran Investments, adding an estimated $8.59M. The largest seller was State Street, cutting an estimated $6.85M.

  • 202 institutional investors held MiMedx Group (MDXG) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $657M of MiMedx Group stock for Q2 2024, down 8.8% quarter-over-quarter.
  • 29 funds opened new MiMedx Group positions in Q2 2024 and 26 closed out, a net change of +3 holders.
  • The largest MiMedx Group buyer in Q2 2024 was Trigran Investments, an estimated $8.59M added.
  • The largest MiMedx Group seller in Q2 2024 was State Street, an estimated $6.85M sold.

Based on aggregated 13F filings for Q2 2024.